Home / Netherlands / DSM-Firmenich AG
DSM-Firmenich AG
Short position disclosed on September 14, 2026.
Evolution of the disclosed total
October 24, 2023 today
Open positions
| Fund | Twelve months | % of capital | Over the year | Since |
|---|---|---|---|---|
| Ilex Capital Partners (UK) LLP | 2.10% | +1.26 pt | July 31, 2026 | |
| Marshall Wace LLP | 0.78% | new | September 14, 2026 | |
| Capital Fund Management S.A. | 0.60% | new | September 7, 2026 |
In the United States DSMFF (OTC): 515,944 shares sold short on September 15, 2026. FINRA names no fund.
On the other side: the funds that hold DSM-Firmenich AG Titelia
Get the moves on DSM-Firmenich AG by mail.
There is no account to create. You give an address, you confirm it through a link, and every message contains a link to stop.
History of disclosures
Download 74 filings as CSV Columns: Date, Fund, Market, Disclosed position, Unit, End date. The other formats
Other companies sold short in the Netherlands
- Akzo Nobel N.V. 9.86% of the capital sold short
- Pharming Group N.V. 7.95% of the capital sold short
- Signify N.V. 7.52% of the capital sold short
- Imcd N.V. 4.65% of the capital sold short
- Fugro N.V. 4.20% of the capital sold short
- Basic-Fit N.V. 3.43% of the capital sold short
- PostNL N.V. 2.55% of the capital sold short
- NSI N.V. 2.01% of the capital sold short
- Alfen N.V. 1.85% of the capital sold short
- Arcadis N.V. 1.72% of the capital sold short
- Sligro Food Group N.V. 1.55% of the capital sold short
- Avantium N.V. 1.39% of the capital sold short
Cite this page
The figure comes from the regulator register, not from this site. Quoting both lets your reader check it.
QuiVad, DSM-Firmenich AG, source AFM, data as at September 14, 2026, https://www.quivad.com/action/dsm-firmenich-ag?page=2